{
  "url": "https://www.nature.com/articles/s41590-025-02316-2",
  "title": "Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer - Nature Immunology",
  "description": "Kallies and colleagues examine the role of the chromatin regulator SATB1 in CD8⁺ T cell differentiation during viral infection and cancer. They show that SATB1 is a negative regulator of exhausted CD8⁺ T cell expansion and effector differentiation.",
  "links": [
    "https://www.nature.com/articles/s41590-025-02316-2"
  ],
  "image": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41590-025-02316-2/MediaObjects/41590_2025_2316_Fig1_HTML.png",
  "content": "<div>\n                <div><h2 id=\"data-availability\">Data availability</h2><p>The ATAC-seq and RNA-seq data are available under accession numbers <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281275\">GSE281275</a> and <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281382\">GSE281382</a>.</p></div><div><h2 id=\"Bib1\">References</h2><div><ol><li><p>McLane, L. M., Abdel-Hakeem, M. S. &amp; Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. <i>Annu. Rev. Immunol.</i> <b>37</b>, 457–495 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1146%2Fannurev-immunol-041015-055318\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhslahsbs%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30676822\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=CD8%20T%20cell%20exhaustion%20during%20chronic%20viral%20infection%20and%20cancer&amp;journal=Annu.%20Rev.%20Immunol.&amp;doi=10.1146%2Fannurev-immunol-041015-055318&amp;volume=37&amp;pages=457-495&amp;publication_year=2019&amp;author=McLane%2CLM&amp;author=Abdel-Hakeem%2CMS&amp;author=Wherry%2CEJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Blank, C. U. et al. Defining ‘T cell exhaustion’. <i>Nat. Rev. Immunol.</i> <b>19</b>, 665–674 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41577-019-0221-9\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhvVOqurbP\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31570879\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286441\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Defining%20%E2%80%98T%20cell%20exhaustion%E2%80%99&amp;journal=Nat.%20Rev.%20Immunol.&amp;doi=10.1038%2Fs41577-019-0221-9&amp;volume=19&amp;pages=665-674&amp;publication_year=2019&amp;author=Blank%2CCU\">\n                    Google Scholar</a> \n                </p></li><li><p>Kallies, A., Zehn, D. &amp; Utzschneider, D. T. Precursor exhausted T cells: key to successful immunotherapy?. <i>Nat. Rev. Immunol.</i> <b>20</b>, 128–136 (2020).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41577-019-0223-7\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhvFejs77J\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31591533\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Precursor%20exhausted%20T%20cells%3A%20key%20to%20successful%20immunotherapy%3F&amp;journal=Nat.%20Rev.%20Immunol.&amp;doi=10.1038%2Fs41577-019-0223-7&amp;volume=20&amp;pages=128-136&amp;publication_year=2020&amp;author=Kallies%2CA&amp;author=Zehn%2CD&amp;author=Utzschneider%2CDT\">\n                    Google Scholar</a> \n                </p></li><li><p>Zehn, D., Thimme, R., Lugli, E., de Almeida, G. P. &amp; Oxenius, A. ‘Stem-like’ precursors are the fount to sustain persistent CD8<sup>+</sup> T cell responses. <i>Nat. Immunol.</i> <b>23</b>, 836–847 (2022).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41590-022-01219-w\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38Xhtl2jsLjJ\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35624209\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=%E2%80%98Stem-like%E2%80%99%20precursors%20are%20the%20fount%20to%20sustain%20persistent%20CD8%2B%20T%20cell%20responses&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fs41590-022-01219-w&amp;volume=23&amp;pages=836-847&amp;publication_year=2022&amp;author=Zehn%2CD&amp;author=Thimme%2CR&amp;author=Lugli%2CE&amp;author=Almeida%2CGP&amp;author=Oxenius%2CA\">\n                    Google Scholar</a> \n                </p></li><li><p>Rausch, L. &amp; Kallies, A. Molecular mechanisms governing CD8 T cell differentiation and checkpoint inhibitor response in cancer. <i>Annu. Rev. Immunol.</i> <b>43</b>, 515–543 (2025).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1146%2Fannurev-immunol-082223-044122\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB2MXpvVKhtLg%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=40279308\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Molecular%20mechanisms%20governing%20CD8%20T%20cell%20differentiation%20and%20checkpoint%20inhibitor%20response%20in%20cancer&amp;journal=Annu.%20Rev.%20Immunol.&amp;doi=10.1146%2Fannurev-immunol-082223-044122&amp;volume=43&amp;pages=515-543&amp;publication_year=2025&amp;author=Rausch%2CL&amp;author=Kallies%2CA\">\n                    Google Scholar</a> \n                </p></li><li><p>Thommen, D. S. &amp; Schumacher, T. N. T cell dysfunction in cancer. <i>Cancer Cell</i> <b>33</b>, 547–562 (2018).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.ccell.2018.03.012\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXntlCitLk%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29634943\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116508\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=T%20cell%20dysfunction%20in%20cancer&amp;journal=Cancer%20Cell&amp;doi=10.1016%2Fj.ccell.2018.03.012&amp;volume=33&amp;pages=547-562&amp;publication_year=2018&amp;author=Thommen%2CDS&amp;author=Schumacher%2CTN\">\n                    Google Scholar</a> \n                </p></li><li><p>Ribas, A. &amp; Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. <i>Science</i> <b>359</b>, 1350–1355 (2018).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1126%2Fscience.aar4060\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXltFehtb8%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29567705\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391259\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Cancer%20immunotherapy%20using%20checkpoint%20blockade&amp;journal=Science&amp;doi=10.1126%2Fscience.aar4060&amp;volume=359&amp;pages=1350-1355&amp;publication_year=2018&amp;author=Ribas%2CA&amp;author=Wolchok%2CJD\">\n                    Google Scholar</a> \n                </p></li><li><p>Albelda, S. M. CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. <i>Nat. Rev. Clin. Oncol.</i> <b>21</b>, 47–66 (2024).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41571-023-00832-4\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37904019\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=CAR%20T%20cell%20therapy%20for%20patients%20with%20solid%20tumours%3A%20key%20lessons%20to%20learn%20and%20unlearn&amp;journal=Nat.%20Rev.%20Clin.%20Oncol.&amp;doi=10.1038%2Fs41571-023-00832-4&amp;volume=21&amp;pages=47-66&amp;publication_year=2024&amp;author=Albelda%2CSM\">\n                    Google Scholar</a> \n                </p></li><li><p>Chan, J. D. et al. Cellular networks controlling T cell persistence in adoptive cell therapy. <i>Nat. Rev. Immunol.</i> <b>21</b>, 769–784 (2021).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41577-021-00539-6\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXptlOgs7c%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33879873\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Cellular%20networks%20controlling%20T%20cell%20persistence%20in%20adoptive%20cell%20therapy&amp;journal=Nat.%20Rev.%20Immunol.&amp;doi=10.1038%2Fs41577-021-00539-6&amp;volume=21&amp;pages=769-784&amp;publication_year=2021&amp;author=Chan%2CJD\">\n                    Google Scholar</a> \n                </p></li><li><p>Martinez, G. J. et al. The transcription factor NFAT promotes exhaustion of activated CD8<sup>+</sup> T cells. <i>Immunity</i> <b>42</b>, 265–278 (2015).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2015.01.006\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXisVygt74%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25680272\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346317\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20transcription%20factor%20NFAT%20promotes%20exhaustion%20of%20activated%20CD8%2B%20T%20cells&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2015.01.006&amp;volume=42&amp;pages=265-278&amp;publication_year=2015&amp;author=Martinez%2CGJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Man, K. et al. Transcription factor IRF4 promotes CD8<sup>+</sup> T cell exhaustion and limits the development of memory-like T cells during chronic infection. <i>Immunity</i> <b>47</b>, 1129–1141 (2017).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2017.11.021\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhvFKgsr3K\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29246443\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Transcription%20factor%20IRF4%20promotes%20CD8%2B%20T%20cell%20exhaustion%20and%20limits%20the%20development%20of%20memory-like%20T%20cells%20during%20chronic%20infection&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2017.11.021&amp;volume=47&amp;pages=1129-1141&amp;publication_year=2017&amp;author=Man%2CK\">\n                    Google Scholar</a> \n                </p></li><li><p>Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. <i>Nature</i> <b>571</b>, 265–269 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41586-019-1326-9\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhtlSms7bP\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31207605\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=TOX%20reinforces%20the%20phenotype%20and%20longevity%20of%20exhausted%20T%20cells%20in%20chronic%20viral%20infection&amp;journal=Nature&amp;doi=10.1038%2Fs41586-019-1326-9&amp;volume=571&amp;pages=265-269&amp;publication_year=2019&amp;author=Alfei%2CF\">\n                    Google Scholar</a> \n                </p></li><li><p>Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. <i>Nature</i> <b>571</b>, 270–274 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41586-019-1324-y\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhtlamtbzI\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31207604\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698992\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=TOX%20is%20a%20critical%20regulator%20of%20tumour-specific%20T%20cell%20differentiation&amp;journal=Nature&amp;doi=10.1038%2Fs41586-019-1324-y&amp;volume=571&amp;pages=270-274&amp;publication_year=2019&amp;author=Scott%2CAC\">\n                    Google Scholar</a> \n                </p></li><li><p>Liu, X. et al. Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction. <i>Nature</i> <b>567</b>, 525–529 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41586-019-0979-8\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXmsVyqtb4%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30814730\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507425\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Genome-wide%20analysis%20identifies%20NR4A1%20as%20a%20key%20mediator%20of%20T%20cell%20dysfunction&amp;journal=Nature&amp;doi=10.1038%2Fs41586-019-0979-8&amp;volume=567&amp;pages=525-529&amp;publication_year=2019&amp;author=Liu%2CX\">\n                    Google Scholar</a> \n                </p></li><li><p>Khan, O. et al. TOX transcriptionally and epigenetically programs CD8<sup>+</sup> T cell exhaustion. <i>Nature</i> <b>571</b>, 211–218 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41586-019-1325-x\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhtlSms7bI\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31207603\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713202\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=TOX%20transcriptionally%20and%20epigenetically%20programs%20CD8%2B%20T%20cell%20exhaustion&amp;journal=Nature&amp;doi=10.1038%2Fs41586-019-1325-x&amp;volume=571&amp;pages=211-218&amp;publication_year=2019&amp;author=Khan%2CO\">\n                    Google Scholar</a> \n                </p></li><li><p>Seo, H. et al. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8<sup>+</sup> T cell exhaustion. <i>Proc. Natl Acad. Sci. USA</i> <b>116</b>, 12410–12415 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1073%2Fpnas.1905675116\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhtFyksbfO\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31152140\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589758\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=TOX%20and%20TOX2%20transcription%20factors%20cooperate%20with%20NR4A%20transcription%20factors%20to%20impose%20CD8%2B%20T%20cell%20exhaustion&amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;doi=10.1073%2Fpnas.1905675116&amp;volume=116&amp;pages=12410-12415&amp;publication_year=2019&amp;author=Seo%2CH\">\n                    Google Scholar</a> \n                </p></li><li><p>He, R. et al. Follicular CXCR5-expressing CD8<sup>+</sup> T cells curtail chronic viral infection. <i>Nature</i> <b>537</b>, 412–428 (2016).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fnature19317\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28XhsFajsr3N\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27501245\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Follicular%20CXCR5-expressing%20CD8%2B%20T%20cells%20curtail%20chronic%20viral%20infection&amp;journal=Nature&amp;doi=10.1038%2Fnature19317&amp;volume=537&amp;pages=412-428&amp;publication_year=2016&amp;author=He%2CR\">\n                    Google Scholar</a> \n                </p></li><li><p>Im, S. J. et al. Defining CD8<sup>+</sup> T cells that provide the proliferative burst after PD-1 therapy. <i>Nature</i> <b>537</b>, 417–421 (2016).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fnature19330\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28XhsFajsrzE\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27501248\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297183\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Defining%20CD8%2B%20T%20cells%20that%20provide%20the%20proliferative%20burst%20after%20PD-1%20therapy&amp;journal=Nature&amp;doi=10.1038%2Fnature19330&amp;volume=537&amp;pages=417-421&amp;publication_year=2016&amp;author=Im%2CSJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8<sup>+</sup> T cells sustain the immune response to chronic viral infections. <i>Immunity</i> <b>45</b>, 415–427 (2016).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2016.07.021\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28XhtlOqsr7P\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27533016\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=T%20cell%20factor%201-expressing%20memory-like%20CD8%2B%20T%20cells%20sustain%20the%20immune%20response%20to%20chronic%20viral%20infections&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2016.07.021&amp;volume=45&amp;pages=415-427&amp;publication_year=2016&amp;author=Utzschneider%2CDT\">\n                    Google Scholar</a> \n                </p></li><li><p>Leong, Y. A. et al. CXCR5<sup>+</sup> follicular cytotoxic T cells control viral infection in B cell follicles. <i>Nat. Immunol.</i> <b>17</b>, 1187–1196 (2016).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fni.3543\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28XhtlSgt7rJ\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27487330\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=CXCR5%2B%20follicular%20cytotoxic%20T%20cells%20control%20viral%20infection%20in%20B%20cell%20follicles&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fni.3543&amp;volume=17&amp;pages=1187-1196&amp;publication_year=2016&amp;author=Leong%2CYA\">\n                    Google Scholar</a> \n                </p></li><li><p>Wu, T. et al. The TCF1–BCL6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness. <i>Sci. Immunol.</i> <b>1</b>, eaai8593 (2016).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1126%2Fsciimmunol.aai8593\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28018990\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179228\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20TCF1%E2%80%93BCL6%20axis%20counteracts%20type%20I%20interferon%20to%20repress%20exhaustion%20and%20maintain%20T%20cell%20stemness&amp;journal=Sci.%20Immunol.&amp;doi=10.1126%2Fsciimmunol.aai8593&amp;volume=1&amp;publication_year=2016&amp;author=Wu%2CT\">\n                    Google Scholar</a> \n                </p></li><li><p>Miller, B. C. et al. Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockade. <i>Nat. Immunol.</i> <b>20</b>, 326–336 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41590-019-0312-6\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXnsVCitbg%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30778252\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6673650\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Subsets%20of%20exhausted%20CD8%2B%20T%20cells%20differentially%20mediate%20tumor%20control%20and%20respond%20to%20checkpoint%20blockade&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fs41590-019-0312-6&amp;volume=20&amp;pages=326-336&amp;publication_year=2019&amp;author=Miller%2CBC\">\n                    Google Scholar</a> \n                </p></li><li><p>Utzschneider, D. T. et al. Early precursor T cells establish and propagate T cell exhaustion in chronic infection. <i>Nat. Immunol.</i> <b>21</b>, 1256–1266 (2020).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41590-020-0760-z\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhs1KjsrzL\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32839610\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Early%20precursor%20T%20cells%20establish%20and%20propagate%20T%20cell%20exhaustion%20in%20chronic%20infection&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fs41590-020-0760-z&amp;volume=21&amp;pages=1256-1266&amp;publication_year=2020&amp;author=Utzschneider%2CDT\">\n                    Google Scholar</a> \n                </p></li><li><p>Siddiqui, I. et al. Intratumoral TCF1<sup>+</sup>PD-1<sup>+</sup>CD8<sup>+</sup> T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. <i>Immunity</i> <b>50</b>, 195–211 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2018.12.021\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXls1SjsQ%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30635237\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Intratumoral%20TCF1%2BPD-1%2BCD8%2B%20T%20cells%20with%20stem-like%20properties%20promote%20tumor%20control%20in%20response%20to%20vaccination%20and%20checkpoint%20blockade%20immunotherapy&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2018.12.021&amp;volume=50&amp;pages=195-211&amp;publication_year=2019&amp;author=Siddiqui%2CI\">\n                    Google Scholar</a> \n                </p></li><li><p>Tsui, C. et al. MYB orchestrates T cell exhaustion and response to checkpoint inhibition. <i>Nature</i> <b>609</b>, 354–360 (2022).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41586-022-05105-1\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XitFGlsr3I\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35978192\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452299\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=MYB%20orchestrates%20T%20cell%20exhaustion%20and%20response%20to%20checkpoint%20inhibition&amp;journal=Nature&amp;doi=10.1038%2Fs41586-022-05105-1&amp;volume=609&amp;pages=354-360&amp;publication_year=2022&amp;author=Tsui%2CC\">\n                    Google Scholar</a> \n                </p></li><li><p>Wijesinghe, S. K. M. et al. Lymph-node-derived stem-like but not tumor-tissue-resident CD8<sup>+</sup> T cells fuel anticancer immunity. <i>Nat. Immunol.</i> <b>26</b>, 1367–1383 (2025).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41590-025-02219-2\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB2MXhslyitLbP\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=40730900\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Lymph-node-derived%20stem-like%20but%20not%20tumor-tissue-resident%20CD8%2B%20T%20cells%20fuel%20anticancer%20immunity&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fs41590-025-02219-2&amp;volume=26&amp;pages=1367-1383&amp;publication_year=2025&amp;author=Wijesinghe%2CSKM\">\n                    Google Scholar</a> \n                </p></li><li><p>Hudson, W. H. et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1<sup>+</sup> stem-like CD8<sup>+</sup> T cells during chronic infection. <i>Immunity</i> <b>51</b>, 1043–1058 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2019.11.002\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXit12ht7nN\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31810882\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920571\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Proliferating%20transitory%20T%20cells%20with%20an%20effector-like%20transcriptional%20signature%20emerge%20from%20PD-1%2B%20stem-like%20CD8%2B%20T%20cells%20during%20chronic%20infection&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2019.11.002&amp;volume=51&amp;pages=1043-1058&amp;publication_year=2019&amp;author=Hudson%2CWH\">\n                    Google Scholar</a> \n                </p></li><li><p>Zander, R. et al. CD4<sup>+</sup> T cell help is required for the formation of a cytolytic CD8<sup>+</sup> T cell subset that protects against chronic infection and cancer. <i>Immunity</i> <b>51</b>, 1028–1042 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2019.10.009\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXit12ht7nO\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31810883\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929322\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=CD4%2B%20T%20cell%20help%20is%20required%20for%20the%20formation%20of%20a%20cytolytic%20CD8%2B%20T%20cell%20subset%20that%20protects%20against%20chronic%20infection%20and%20cancer&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2019.10.009&amp;volume=51&amp;pages=1028-1042&amp;publication_year=2019&amp;author=Zander%2CR\">\n                    Google Scholar</a> \n                </p></li><li><p>Rahim, M. K. et al. Dynamic CD8<sup>+</sup> T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. <i>Cell</i> <b>186</b>, 1127–1143 (2023).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.cell.2023.02.021\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXlsVCju7o%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=36931243\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348701\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Dynamic%20CD8%2B%20T%20cell%20responses%20to%20cancer%20immunotherapy%20in%20human%20regional%20lymph%20nodes%20are%20disrupted%20in%20metastatic%20lymph%20nodes&amp;journal=Cell&amp;doi=10.1016%2Fj.cell.2023.02.021&amp;volume=186&amp;pages=1127-1143&amp;publication_year=2023&amp;author=Rahim%2CMK\">\n                    Google Scholar</a> \n                </p></li><li><p>Tsui, C. et al. Lymph nodes fuel KLF2-dependent effector CD8<sup>+</sup> T cell differentiation during chronic infection and checkpoint blockade. <i>Nat. Immunol</i>. <b>26</b>, 1752–1765 (2025).</p></li><li><p>Yamauchi, T. et al. T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors. <i>Nat. Commun.</i> <b>12</b>, 1402 (2021).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41467-021-21619-0\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXlvVyqtbg%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33658501\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930182\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=T-cell%20CX3CR1%20expression%20as%20a%20dynamic%20blood-based%20biomarker%20of%20response%20to%20immune%20checkpoint%20inhibitors&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-021-21619-0&amp;volume=12&amp;publication_year=2021&amp;author=Yamauchi%2CT\">\n                    Google Scholar</a> \n                </p></li><li><p>Sen, D. R. et al. The epigenetic landscape of T cell exhaustion. <i>Science</i> <b>354</b>, 1165–1169 (2016).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1126%2Fscience.aae0491\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28XhvFGrt7fK\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27789799\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497589\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20epigenetic%20landscape%20of%20T%20cell%20exhaustion&amp;journal=Science&amp;doi=10.1126%2Fscience.aae0491&amp;volume=354&amp;pages=1165-1169&amp;publication_year=2016&amp;author=Sen%2CDR\">\n                    Google Scholar</a> \n                </p></li><li><p>Philip, M. et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. <i>Nature</i> <b>545</b>, 452–456 (2017).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fnature22367\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXnvVCrsrc%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28514453\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693219\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Chromatin%20states%20define%20tumour-specific%20T%20cell%20dysfunction%20and%20reprogramming&amp;journal=Nature&amp;doi=10.1038%2Fnature22367&amp;volume=545&amp;pages=452-456&amp;publication_year=2017&amp;author=Philip%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Ghoneim, H. E. et al. De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation. <i>Cell</i> <b>170</b>, 142–157 (2017).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.cell.2017.06.007\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhtVOjsbnI\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28648661\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568784\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=De%20novo%20epigenetic%20programs%20inhibit%20PD-1%20blockade-mediated%20T%20cell%20rejuvenation&amp;journal=Cell&amp;doi=10.1016%2Fj.cell.2017.06.007&amp;volume=170&amp;pages=142-157&amp;publication_year=2017&amp;author=Ghoneim%2CHE\">\n                    Google Scholar</a> \n                </p></li><li><p>Hao, B. et al. An anti-silencer- and SATB1-dependent chromatin hub regulates <i>Rag1</i> and <i>Rag2</i> gene expression during thymocyte development. <i>J. Exp. Med.</i> <b>212</b>, 809–824 (2015).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1084%2Fjem.20142207\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXoslaisbo%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25847946\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419350\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=An%20anti-silencer-%20and%20SATB1-dependent%20chromatin%20hub%20regulates%20Rag1%20and%20Rag2%20gene%20expression%20during%20thymocyte%20development&amp;journal=J.%20Exp.%20Med.&amp;doi=10.1084%2Fjem.20142207&amp;volume=212&amp;pages=809-824&amp;publication_year=2015&amp;author=Hao%2CB\">\n                    Google Scholar</a> \n                </p></li><li><p>Kakugawa, K. et al. Essential roles of SATB1 in specifying T lymphocyte subsets. <i>Cell Rep.</i> <b>19</b>, 1176–1188 (2017).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.celrep.2017.04.038\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXnsFeht7g%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28494867\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Essential%20roles%20of%20SATB1%20in%20specifying%20T%20lymphocyte%20subsets&amp;journal=Cell%20Rep.&amp;doi=10.1016%2Fj.celrep.2017.04.038&amp;volume=19&amp;pages=1176-1188&amp;publication_year=2017&amp;author=Kakugawa%2CK\">\n                    Google Scholar</a> \n                </p></li><li><p>Chaurio, R. A. et al. TGF-β-mediated silencing of genomic organizer SATB1 promotes T<sub>FH</sub> cell differentiation and formation of intra-tumoral tertiary lymphoid structures. <i>Immunity</i> <b>55</b>, 115–128 (2022).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2021.12.007\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XotlGksg%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35021053\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852221\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=TGF-%CE%B2-mediated%20silencing%20of%20genomic%20organizer%20SATB1%20promotes%20TFH%20cell%20differentiation%20and%20formation%20of%20intra-tumoral%20tertiary%20lymphoid%20structures&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2021.12.007&amp;volume=55&amp;pages=115-128&amp;publication_year=2022&amp;author=Chaurio%2CRA\">\n                    Google Scholar</a> \n                </p></li><li><p>Yasuda, K. et al. SATB1 regulates the effector program of encephalitogenic tissue T<sub>H</sub>17 cells in chronic inflammation. <i>Nat. Commun.</i> <b>10</b>, 549 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41467-019-08404-w\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXntlKltbg%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30710091\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358604\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=SATB1%20regulates%20the%20effector%20program%20of%20encephalitogenic%20tissue%20TH17%20cells%20in%20chronic%20inflammation&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-019-08404-w&amp;volume=10&amp;publication_year=2019&amp;author=Yasuda%2CK\">\n                    Google Scholar</a> \n                </p></li><li><p>Kitagawa, Y. et al. Guidance of regulatory T cell development by SATB1-dependent super-enhancer establishment. <i>Nat. Immunol.</i> <b>18</b>, 173–183 (2017).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fni.3646\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28XitFSntrbN\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27992401\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Guidance%20of%20regulatory%20T%20cell%20development%20by%20SATB1-dependent%20super-enhancer%20establishment&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fni.3646&amp;volume=18&amp;pages=173-183&amp;publication_year=2017&amp;author=Kitagawa%2CY\">\n                    Google Scholar</a> \n                </p></li><li><p>Nussing, S. et al. SATB1 ensures appropriate transcriptional programs within naive CD8<sup>+</sup> T cells. <i>Immunol. Cell Biol.</i> <b>100</b>, 636–652 (2022).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1111%2Fimcb.12566\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35713361\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542893\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=SATB1%20ensures%20appropriate%20transcriptional%20programs%20within%20naive%20CD8%2B%20T%20cells&amp;journal=Immunol.%20Cell%20Biol.&amp;doi=10.1111%2Fimcb.12566&amp;volume=100&amp;pages=636-652&amp;publication_year=2022&amp;author=Nussing%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Stephen, T. L. et al. SATB1 expression governs epigenetic repression of PD-1 in tumor-reactive T cells. <i>Immunity</i> <b>46</b>, 51–64 (2017).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2016.12.015\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXht1antL0%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28099864\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336605\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=SATB1%20expression%20governs%20epigenetic%20repression%20of%20PD-1%20in%20tumor-reactive%20T%20cells&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2016.12.015&amp;volume=46&amp;pages=51-64&amp;publication_year=2017&amp;author=Stephen%2CTL\">\n                    Google Scholar</a> \n                </p></li><li><p>Nussing, S. et al. Divergent SATB1 expression across human life span and tissue compartments. <i>Immunol. Cell Biol.</i> <b>97</b>, 498–511 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1111%2Fimcb.12233\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30803026\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618325\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Divergent%20SATB1%20expression%20across%20human%20life%20span%20and%20tissue%20compartments&amp;journal=Immunol.%20Cell%20Biol.&amp;doi=10.1111%2Fimcb.12233&amp;volume=97&amp;pages=498-511&amp;publication_year=2019&amp;author=Nussing%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Maekawa, Y. et al. NOTCH2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. <i>Nat. Immunol.</i> <b>9</b>, 1140–1147 (2008).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fni.1649\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1cXhtFeit7rN\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18724371\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=NOTCH2%20integrates%20signaling%20by%20the%20transcription%20factors%20RBP-J%20and%20CREB1%20to%20promote%20T%20cell%20cytotoxicity&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fni.1649&amp;volume=9&amp;pages=1140-1147&amp;publication_year=2008&amp;author=Maekawa%2CY\">\n                    Google Scholar</a> \n                </p></li><li><p>Sommer, D. et al. Efficient genome engineering by targeted homologous recombination in mouse embryos using transcription activator-like effector nucleases. <i>Nat. Commun.</i> <b>5</b>, 3045 (2014).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fncomms4045\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24413636\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Efficient%20genome%20engineering%20by%20targeted%20homologous%20recombination%20in%20mouse%20embryos%20using%20transcription%20activator-like%20effector%20nucleases&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fncomms4045&amp;volume=5&amp;publication_year=2014&amp;author=Sommer%2CD\">\n                    Google Scholar</a> \n                </p></li><li><p>Kohne, M. et al. SATB1 directs the differentiation of T<sub>H</sub>17 cells through suppression of IL-2 expression. <i>Cell Rep.</i> <b>44</b>, 115866 (2025).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.celrep.2025.115866\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=40531625\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=SATB1%20directs%20the%20differentiation%20of%20TH17%20cells%20through%20suppression%20of%20IL-2%20expression&amp;journal=Cell%20Rep.&amp;doi=10.1016%2Fj.celrep.2025.115866&amp;volume=44&amp;publication_year=2025&amp;author=Kohne%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Gottimukkala, K. P. et al. Regulation of SATB1 during thymocyte development by TCR signaling. <i>Mol. Immunol.</i> <b>77</b>, 34–43 (2016).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.molimm.2016.07.005\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28Xht1eisb7P\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27454343\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612261\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Regulation%20of%20SATB1%20during%20thymocyte%20development%20by%20TCR%20signaling&amp;journal=Mol.%20Immunol.&amp;doi=10.1016%2Fj.molimm.2016.07.005&amp;volume=77&amp;pages=34-43&amp;publication_year=2016&amp;author=Gottimukkala%2CKP\">\n                    Google Scholar</a> \n                </p></li><li><p>Gabriel, S. S. et al. Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection. <i>Immunity</i> <b>54</b>, 1698–1714 (2021).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2021.06.007\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsVyks7%2FE\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34233154\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Transforming%20growth%20factor-%CE%B2-regulated%20mTOR%20activity%20preserves%20cellular%20metabolism%20to%20maintain%20long-term%20T%20cell%20responses%20in%20chronic%20infection&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2021.06.007&amp;volume=54&amp;pages=1698-1714&amp;publication_year=2021&amp;author=Gabriel%2CSS\">\n                    Google Scholar</a> \n                </p></li><li><p>Jadhav, R. R. et al. Epigenetic signature of PD-1<sup>+</sup> TCF1<sup>+</sup> CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade. <i>Proc. Natl Acad. Sci. USA</i> <b>116</b>, 14113–14118 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1073%2Fpnas.1903520116\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhtlCgsrjO\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31227606\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628832\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Epigenetic%20signature%20of%20PD-1%2B%20TCF1%2B%20CD8%20T%20cells%20that%20act%20as%20resource%20cells%20during%20chronic%20viral%20infection%20and%20respond%20to%20PD-1%20blockade&amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;doi=10.1073%2Fpnas.1903520116&amp;volume=116&amp;pages=14113-14118&amp;publication_year=2019&amp;author=Jadhav%2CRR\">\n                    Google Scholar</a> \n                </p></li><li><p>Kallies, A., Xin, A., Belz, G. T. &amp; Nutt, S. L. Blimp-1 transcription factor is required for the differentiation of effector CD8<sup>+</sup> T cells and memory responses. <i>Immunity</i> <b>31</b>, 283–295 (2009).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2009.06.021\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtFOgsL7F\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19664942\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Blimp-1%20transcription%20factor%20is%20required%20for%20the%20differentiation%20of%20effector%20CD8%2B%20T%20cells%20and%20memory%20responses&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2009.06.021&amp;volume=31&amp;pages=283-295&amp;publication_year=2009&amp;author=Kallies%2CA&amp;author=Xin%2CA&amp;author=Belz%2CGT&amp;author=Nutt%2CSL\">\n                    Google Scholar</a> \n                </p></li><li><p>Shin, H. et al. A role for the transcriptional repressor Blimp-1 in CD8<sup>+</sup> T cell exhaustion during chronic viral infection. <i>Immunity</i> <b>31</b>, 309–320 (2009).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2009.06.019\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtFOgsL%2FN\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19664943\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747257\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=A%20role%20for%20the%20transcriptional%20repressor%20Blimp-1%20in%20CD8%2B%20T%20cell%20exhaustion%20during%20chronic%20viral%20infection&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2009.06.019&amp;volume=31&amp;pages=309-320&amp;publication_year=2009&amp;author=Shin%2CH\">\n                    Google Scholar</a> \n                </p></li><li><p>Fransen, M. F. et al. Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy. <i>JCI Insight</i> <b>3</b>, e124507 (2018).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1172%2Fjci.insight.124507\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30518694\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328025\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Tumor-draining%20lymph%20nodes%20are%20pivotal%20in%20PD-1%2FPD-L1%20checkpoint%20therapy&amp;journal=JCI%20Insight&amp;doi=10.1172%2Fjci.insight.124507&amp;volume=3&amp;publication_year=2018&amp;author=Fransen%2CMF\">\n                    Google Scholar</a> \n                </p></li><li><p>Huang, Q. et al. The primordial differentiation of tumor-specific memory CD8<sup>+</sup> T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes. <i>Cell</i> <b>185</b>, 4049–4066 (2022).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.cell.2022.09.020\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XisFynsbzE\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=36208623\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20primordial%20differentiation%20of%20tumor-specific%20memory%20CD8%2B%20T%20cells%20as%20bona%20fide%20responders%20to%20PD-1%2FPD-L1%20blockade%20in%20draining%20lymph%20nodes&amp;journal=Cell&amp;doi=10.1016%2Fj.cell.2022.09.020&amp;volume=185&amp;pages=4049-4066&amp;publication_year=2022&amp;author=Huang%2CQ\">\n                    Google Scholar</a> \n                </p></li><li><p>Dammeijer, F. et al. The PD-1/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes. <i>Cancer Cell</i> <b>38</b>, 685–700 (2020).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.ccell.2020.09.001\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvFyqt7rN\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33007259\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20PD-1%2FPD-L1-checkpoint%20restrains%20T%20cell%20immunity%20in%20tumor-draining%20lymph%20nodes&amp;journal=Cancer%20Cell&amp;doi=10.1016%2Fj.ccell.2020.09.001&amp;volume=38&amp;pages=685-700&amp;publication_year=2020&amp;author=Dammeijer%2CF\">\n                    Google Scholar</a> \n                </p></li><li><p>Schenkel, J. M. et al. Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1<sup>+</sup> CD8<sup>+</sup> T cells in tumor-draining lymph nodes. <i>Immunity</i> <b>54</b>, 2338–2353 (2021).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.immuni.2021.08.026\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXitVCgsLjN\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34534439\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604155\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Conventional%20type%20I%20dendritic%20cells%20maintain%20a%20reservoir%20of%20proliferative%20tumor-antigen%20specific%20TCF-1%2B%20CD8%2B%20T%20cells%20in%20tumor-draining%20lymph%20nodes&amp;journal=Immunity&amp;doi=10.1016%2Fj.immuni.2021.08.026&amp;volume=54&amp;pages=2338-2353&amp;publication_year=2021&amp;author=Schenkel%2CJM\">\n                    Google Scholar</a> \n                </p></li><li><p>Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. <i>Cell</i> <b>176</b>, 404 (2019).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.cell.2018.12.034\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXovFyqtA%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30633907\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647017\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Defining%20T%20cell%20states%20associated%20with%20response%20to%20checkpoint%20immunotherapy%20in%20melanoma&amp;journal=Cell&amp;doi=10.1016%2Fj.cell.2018.12.034&amp;volume=176&amp;publication_year=2019&amp;author=Sade-Feldman%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Gago da Graca, C. et al. Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression. <i>Sci. Immunol.</i> <b>10</b>, eadn1945 (2025).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1126%2Fsciimmunol.adn1945\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB2MXjtlOlsLw%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39888981\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Stem-like%20memory%20and%20precursors%20of%20exhausted%20T%20cells%20share%20a%20common%20progenitor%20defined%20by%20ID3%20expression&amp;journal=Sci.%20Immunol.&amp;doi=10.1126%2Fsciimmunol.adn1945&amp;volume=10&amp;publication_year=2025&amp;author=Gago%20da%20Graca%2CC\">\n                    Google Scholar</a> \n                </p></li><li><p>Cai, S., Lee, C. C. &amp; Kohwi-Shigematsu, T. SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. <i>Nat. Genet.</i> <b>38</b>, 1278–1288 (2006).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fng1913\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD28XhtFeisbnN\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17057718\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=SATB1%20packages%20densely%20looped%2C%20transcriptionally%20active%20chromatin%20for%20coordinated%20expression%20of%20cytokine%20genes&amp;journal=Nat.%20Genet.&amp;doi=10.1038%2Fng1913&amp;volume=38&amp;pages=1278-1288&amp;publication_year=2006&amp;author=Cai%2CS&amp;author=Lee%2CCC&amp;author=Kohwi-Shigematsu%2CT\">\n                    Google Scholar</a> \n                </p></li><li><p>Ahlfors, H. et al. SATB1 dictates expression of multiple genes including IL-5 involved in human T helper cell differentiation. <i>Blood</i> <b>116</b>, 1443–1453 (2010).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1182%2Fblood-2009-11-252205\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtF2qsb%2FI\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20522714\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938835\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=SATB1%20dictates%20expression%20of%20multiple%20genes%20including%20IL-5%20involved%20in%20human%20T%20helper%20cell%20differentiation&amp;journal=Blood&amp;doi=10.1182%2Fblood-2009-11-252205&amp;volume=116&amp;pages=1443-1453&amp;publication_year=2010&amp;author=Ahlfors%2CH\">\n                    Google Scholar</a> \n                </p></li><li><p>Wang, B., Ji, L. &amp; Bian, Q. SATB1 regulates 3D genome architecture in T cells by constraining chromatin interactions surrounding CTCF-binding sites. <i>Cell Rep.</i> <b>42</b>, 112323 (2023).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.celrep.2023.112323\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXmt12ms7o%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37000624\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=SATB1%20regulates%203D%20genome%20architecture%20in%20T%20cells%20by%20constraining%20chromatin%20interactions%20surrounding%20CTCF-binding%20sites&amp;journal=Cell%20Rep.&amp;doi=10.1016%2Fj.celrep.2023.112323&amp;volume=42&amp;publication_year=2023&amp;author=Wang%2CB&amp;author=Ji%2CL&amp;author=Bian%2CQ\">\n                    Google Scholar</a> \n                </p></li><li><p>Russ, B. E. et al. Active maintenance of CD8<sup>+</sup> T cell naivety through regulation of global genome architecture. <i>Cell Rep.</i> <b>42</b>, 113301 (2023).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.celrep.2023.113301\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXitFenu7vN\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37858463\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679840\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Active%20maintenance%20of%20CD8%2B%20T%20cell%20naivety%20through%20regulation%20of%20global%20genome%20architecture&amp;journal=Cell%20Rep.&amp;doi=10.1016%2Fj.celrep.2023.113301&amp;volume=42&amp;publication_year=2023&amp;author=Russ%2CBE\">\n                    Google Scholar</a> \n                </p></li><li><p>Leveen, P. et al. Induced disruption of the transforming growth factor β type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. <i>Blood</i> <b>100</b>, 560–568 (2002).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1182%2Fblood.V100.2.560\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD38XlsVWgtL8%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12091349\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Induced%20disruption%20of%20the%20transforming%20growth%20factor%20%CE%B2%20type%20II%20receptor%20gene%20in%20mice%20causes%20a%20lethal%20inflammatory%20disorder%20that%20is%20transplantable&amp;journal=Blood&amp;doi=10.1182%2Fblood.V100.2.560&amp;volume=100&amp;pages=560-568&amp;publication_year=2002&amp;author=Leveen%2CP\">\n                    Google Scholar</a> \n                </p></li><li><p>Utzschneider, D. T. et al. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion. <i>Nat. Immunol.</i> <b>14</b>, 603–610 (2013).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fni.2606\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3sXntVaqs7k%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23644506\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=T%20cells%20maintain%20an%20exhausted%20phenotype%20after%20antigen%20withdrawal%20and%20population%20reexpansion&amp;journal=Nat.%20Immunol.&amp;doi=10.1038%2Fni.2606&amp;volume=14&amp;pages=603-610&amp;publication_year=2013&amp;author=Utzschneider%2CDT\">\n                    Google Scholar</a> \n                </p></li><li><p>Battegay, M. et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. <i>J. Virol. Methods</i> <b>33</b>, 191–198 (1991).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2F0166-0934%2891%2990018-U\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:STN:280:DyaK38%2Fkt1Gmsg%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1939506\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Quantification%20of%20lymphocytic%20choriomeningitis%20virus%20with%20an%20immunological%20focus%20assay%20in%2024-%20or%2096-well%20plates&amp;journal=J.%20Virol.%20Methods&amp;doi=10.1016%2F0166-0934%2891%2990018-U&amp;volume=33&amp;pages=191-198&amp;publication_year=1991&amp;author=Battegay%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Giuffrida, L. et al. CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy. <i>Nat. Commun.</i> <b>12</b>, 3236 (2021).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41467-021-23331-5\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsVOqsb7M\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34050151\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163771\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=CRISPR%2FCas9%20mediated%20deletion%20of%20the%20adenosine%20A2A%20receptor%20enhances%20CAR%20T%20cell%20efficacy&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-021-23331-5&amp;volume=12&amp;publication_year=2021&amp;author=Giuffrida%2CL\">\n                    Google Scholar</a> \n                </p></li><li><p>Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. <i>Bioinformatics</i> <b>29</b>, 15–21 (2013).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fbioinformatics%2Fbts635\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC38XhvV2gsbnF\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23104886\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=STAR%3A%20ultrafast%20universal%20RNA-seq%20aligner&amp;journal=Bioinformatics&amp;doi=10.1093%2Fbioinformatics%2Fbts635&amp;volume=29&amp;pages=15-21&amp;publication_year=2013&amp;author=Dobin%2CA\">\n                    Google Scholar</a> \n                </p></li><li><p>Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. <i>Nucleic Acids Res.</i> <b>43</b>, e47 (2015).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fnar%2Fgkv007\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25605792\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402510\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=limma%20powers%20differential%20expression%20analyses%20for%20RNA-sequencing%20and%20microarray%20studies&amp;journal=Nucleic%20Acids%20Res.&amp;doi=10.1093%2Fnar%2Fgkv007&amp;volume=43&amp;publication_year=2015&amp;author=Ritchie%2CME\">\n                    Google Scholar</a> \n                </p></li><li><p>Yu, G., Wang, L. G., Han, Y. &amp; He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. <i>OMICS</i> <b>16</b>, 284–287 (2012).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1089%2Fomi.2011.0118\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC38XmsFarsLw%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22455463\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339379\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=clusterProfiler%3A%20an%20R%20package%20for%20comparing%20biological%20themes%20among%20gene%20clusters&amp;journal=OMICS&amp;doi=10.1089%2Fomi.2011.0118&amp;volume=16&amp;pages=284-287&amp;publication_year=2012&amp;author=Yu%2CG&amp;author=Wang%2CLG&amp;author=Han%2CY&amp;author=He%2CQY\">\n                    Google Scholar</a> \n                </p></li><li><p>Harris, M. A. et al. The Gene Ontology (GO) database and informatics resource. <i>Nucleic Acids Res.</i> <b>32</b>, D258–D261 (2004).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fnar%2Fgkh036\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:STN:280:DC%2BD3srpvFyhtw%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=14681407\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20Gene%20Ontology%20%28GO%29%20database%20and%20informatics%20resource&amp;journal=Nucleic%20Acids%20Res.&amp;doi=10.1093%2Fnar%2Fgkh036&amp;volume=32&amp;pages=D258-D261&amp;publication_year=2004&amp;author=Harris%2CMA\">\n                    Google Scholar</a> \n                </p></li><li><p>Kanehisa, M. &amp; Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. <i>Nucleic Acids Res.</i> <b>28</b>, 27–30 (2000).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fnar%2F28.1.27\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXhvVGqu74%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10592173\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC102409\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=KEGG%3A%20Kyoto%20Encyclopedia%20of%20Genes%20and%20Genomes&amp;journal=Nucleic%20Acids%20Res.&amp;doi=10.1093%2Fnar%2F28.1.27&amp;volume=28&amp;pages=27-30&amp;publication_year=2000&amp;author=Kanehisa%2CM&amp;author=Goto%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. <i>Proc. Natl Acad. Sci. USA</i> <b>102</b>, 15545–15550 (2005).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1073%2Fpnas.0506580102\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD2MXht1ShtrnO\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16199517\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1239896\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Gene%20set%20enrichment%20analysis%3A%20a%20knowledge-based%20approach%20for%20interpreting%20genome-wide%20expression%20profiles&amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;doi=10.1073%2Fpnas.0506580102&amp;volume=102&amp;pages=15545-15550&amp;publication_year=2005&amp;author=Subramanian%2CA\">\n                    Google Scholar</a> \n                </p></li><li><p>Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. <i>Nat. Genet.</i> <b>34</b>, 267–273 (2003).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fng1180\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD3sXkvFSrs7o%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12808457\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=PGC-1%CE%B1-responsive%20genes%20involved%20in%20oxidative%20phosphorylation%20are%20coordinately%20downregulated%20in%20human%20diabetes&amp;journal=Nat.%20Genet.&amp;doi=10.1038%2Fng1180&amp;volume=34&amp;pages=267-273&amp;publication_year=2003&amp;author=Mootha%2CVK\">\n                    Google Scholar</a> \n                </p></li><li><p>Grandi, F. C., Modi, H., Kampman, L. &amp; Corces, M. R. Chromatin accessibility profiling by ATAC–seq. <i>Nat. Protoc.</i> <b>17</b>, 1518–1552 (2022).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41596-022-00692-9\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38Xht1entrzE\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35478247\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189070\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Chromatin%20accessibility%20profiling%20by%20ATAC%E2%80%93seq&amp;journal=Nat.%20Protoc.&amp;doi=10.1038%2Fs41596-022-00692-9&amp;volume=17&amp;pages=1518-1552&amp;publication_year=2022&amp;author=Grandi%2CFC&amp;author=Modi%2CH&amp;author=Kampman%2CL&amp;author=Corces%2CMR\">\n                    Google Scholar</a> \n                </p></li><li><p>Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. <i>EMBnet. J.</i> <b>17</b>, 10–12 (2011).</p><p><a target=\"_blank\" href=\"https://doi.org/10.14806%2Fej.17.1.200\">Article</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Cutadapt%20removes%20adapter%20sequences%20from%20high-throughput%20sequencing%20reads&amp;journal=EMBnet.%20J.&amp;doi=10.14806%2Fej.17.1.200&amp;volume=17&amp;pages=10-12&amp;publication_year=2011&amp;author=Martin%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Danecek, P. et al. Twelve years of SAMtools and BCFtools. <i>Gigascience</i> <b>10</b>, giab008 (2021).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fgigascience%2Fgiab008\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33590861\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931819\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Twelve%20years%20of%20SAMtools%20and%20BCFtools&amp;journal=Gigascience&amp;doi=10.1093%2Fgigascience%2Fgiab008&amp;volume=10&amp;publication_year=2021&amp;author=Danecek%2CP\">\n                    Google Scholar</a> \n                </p></li><li><p>Ramirez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. <i>Nucleic Acids Res.</i> <b>44</b>, W160–W165 (2016).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fnar%2Fgkw257\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhtV2itrfI\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27079975\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987876\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=deepTools2%3A%20a%20next%20generation%20web%20server%20for%20deep-sequencing%20data%20analysis&amp;journal=Nucleic%20Acids%20Res.&amp;doi=10.1093%2Fnar%2Fgkw257&amp;volume=44&amp;pages=W160-W165&amp;publication_year=2016&amp;author=Ramirez%2CF\">\n                    Google Scholar</a> \n                </p></li><li><p>Zhang, Y. et al. Model-based analysis of ChIP–seq (MACS). <i>Genome Biol.</i> <b>9</b>, R137 (2008).</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1186/gb-2008-9-9-r137\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18798982\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592715\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Model-based%20analysis%20of%20ChIP%E2%80%93seq%20%28MACS%29&amp;journal=Genome%20Biol.&amp;doi=10.1186%2Fgb-2008-9-9-r137&amp;volume=9&amp;publication_year=2008&amp;author=Zhang%2CY\">\n                    Google Scholar</a> \n                </p></li><li><p>Liao, Y., Smyth, G. K. &amp; Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. <i>Bioinformatics</i> <b>30</b>, 923–930 (2014).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fbioinformatics%2Fbtt656\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXltFGqu7c%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24227677\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=featureCounts%3A%20an%20efficient%20general%20purpose%20program%20for%20assigning%20sequence%20reads%20to%20genomic%20features&amp;journal=Bioinformatics&amp;doi=10.1093%2Fbioinformatics%2Fbtt656&amp;volume=30&amp;pages=923-930&amp;publication_year=2014&amp;author=Liao%2CY&amp;author=Smyth%2CGK&amp;author=Shi%2CW\">\n                    Google Scholar</a> \n                </p></li><li><p>Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. <i>Nat. Biotechnol.</i> <b>38</b>, 276–278 (2020).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41587-020-0439-x\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXjtFelsbo%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32055031\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20nf-core%20framework%20for%20community-curated%20bioinformatics%20pipelines&amp;journal=Nat.%20Biotechnol.&amp;doi=10.1038%2Fs41587-020-0439-x&amp;volume=38&amp;pages=276-278&amp;publication_year=2020&amp;author=Ewels%2CPA\">\n                    Google Scholar</a> \n                </p></li><li><p>Patel, H. et al. nf-core/atacseq: nf-core/atacseq v1.2.1 - Iron Centipede (1.2.1). <i>Zenodo</i> <a target=\"_blank\" href=\"https://doi.org/10.5281/zenodo.2634132\">https://doi.org/10.5281/zenodo.2634132</a> (2020).</p></li><li><p>Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime <i>cis</i>-regulatory elements required for macrophage and B cell identities. <i>Mol. Cell</i> <b>38</b>, 576–589 (2010).</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.molcel.2010.05.004\">Article</a> \n    <a target=\"_blank\" href=\"https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3cXns1SlsLc%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20513432\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898526\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Simple%20combinations%20of%20lineage-determining%20transcription%20factors%20prime%20cis-regulatory%20elements%20required%20for%20macrophage%20and%20B%20cell%20identities&amp;journal=Mol.%20Cell&amp;doi=10.1016%2Fj.molcel.2010.05.004&amp;volume=38&amp;pages=576-589&amp;publication_year=2010&amp;author=Heinz%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Carlson, M. org.Mm.eg.db: genome wide annotation for mouse. <i>Bioconductor</i> <a target=\"_blank\" href=\"http://bioconductor.org/packages/release/data/annotation/html/org.Mm.eg.db.html\">https://bioconductor.org/packages/release/data/annotation/html/org.Mm.eg.db.html</a> (2000).</p></li></ol><p><a target=\"_blank\" href=\"https://citation-needed.springer.com/v2/references/10.1038/s41590-025-02316-2?format=refman&amp;flavour=references\">Download references</a></p></div></div><div><h2 id=\"Ack1\">Acknowledgements</h2><p>This study was supported by a National Health and Medical Research Council (NHMRC) Investigator Grant (2017420 to A.K.), NHMRC Ideas and Project Grants (1147409 to A.K., 2028921 to L.R. and C.T., 1185346 to A.K. and 1003131 to S.J.T.), an Australian Research Council grant (DE240100827 to C.T.), a Cancer Council grant (to A.K.), the Melbourne Research Scholarship (L.H., S.K.M.W., S.L., M.H.S., C.G.G. and N.T.H.-A.), the Deutsche Forschungsgemeinschaft (DFG) via a Postdoctoral Fellowship (L.R.), IRTG2168 272482170 (Z.A., H.H. and M.D.B.), DFG EXC2151 (390873048 to Z.A. and M.D.B.), CRC237/B15/B17 (369799452 to Z.A.), CRC1454 (432325352) (to Z.A. and M.D.B) and a CSL Centenary Fellowship (D.T.U.). Furthermore, M.D.B. is supported by the EU-funded project NEUROCOV, the RIA HORIZON Research and Innovation under GA 101057775 and the Else–Kröner–Fresenius Foundation (2018_A158). We thank the NIH Tetramer Facility for providing us with tetramers. We thank the Melbourne Cytometry Platform for providing flow cytometry services and the Doherty Institute Biological Resource Facility for animal husbandry and management.</p></div><div><h2 id=\"author-information\">Author information</h2><div><p><span>Author notes</span></p><ol><li><p>These authors contributed equally: Lisa Rausch, Michael H. Shannon.</p></li></ol><h3 id=\"affiliations\">Authors and Affiliations</h3><ol><li><p>Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia</p><p>Leonie Heyden, Lisa Rausch, Michael H. Shannon, Lachlan Dryburgh, Marcela L. Moreira, Aleksej Frolov, Sharanya K. M. Wijesinghe, Sining Li, Nhat Truong Huynh-Anh, Catarina Gago da Graça, Carlson Tsui, Bianca von Scheidt, Simone L. Park, Laura K. Mackay, Daniel T. Utzschneider, Jan Schröder &amp; Axel Kallies</p></li><li><p>Institute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany</p><p>Leonie Heyden, Helena Horvatic, Zeinab Abdullah &amp; Axel Kallies</p></li><li><p>Immunogenomics and Neurodegeneration, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany</p><p>Aleksej Frolov, Maren Köhne &amp; Marc D. Beyer</p></li><li><p>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia</p><p>Christina M. Scheffler, Marit J. van Elsas, Junming Tong, Olivia Hidajat &amp; Phillip K. Darcy</p></li><li><p>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia</p><p>Christina M. Scheffler, Marit J. van Elsas, Junming Tong, Olivia Hidajat &amp; Phillip K. Darcy</p></li><li><p>Genomics and Immunoregulation, LIMES Institute, University of Bonn, Bonn, Germany</p><p>Daniel Sommer</p></li><li><p>Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany</p><p>F. Thomas Wunderlich</p></li><li><p>Department of Microbiology, The Biomedical Discovery Institute, Monash University, Melbourne, Victoria, Australia</p><p>Stephen J. Turner</p></li><li><p>Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany</p><p>Marc D. Beyer</p></li><li><p>PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE, University of Bonn, and West German Genome Center, Bonn, Germany (DZNE), Bonn, Germany</p><p>Marc D. Beyer</p></li></ol><div><p><span>Authors</span></p><ol><li><span>Leonie Heyden</span></li><li><span>Lisa Rausch</span></li><li><span>Michael H. Shannon</span></li><li><span>Lachlan Dryburgh</span></li><li><span>Marcela L. Moreira</span></li><li><span>Aleksej Frolov</span></li><li><span>Christina M. Scheffler</span></li><li><span>Marit J. van Elsas</span></li><li><span>Junming Tong</span></li><li><span>Olivia Hidajat</span></li><li><span>Sharanya K. M. Wijesinghe</span></li><li><span>Sining Li</span></li><li><span>Helena Horvatic</span></li><li><span>Nhat Truong Huynh-Anh</span></li><li><span>Catarina Gago da Graça</span></li><li><span>Carlson Tsui</span></li><li><span>Maren Köhne</span></li><li><span>Daniel Sommer</span></li><li><span>F. Thomas Wunderlich</span></li><li><span>Bianca von Scheidt</span></li><li><span>Simone L. Park</span></li><li><span>Laura K. Mackay</span></li><li><span>Daniel T. Utzschneider</span></li><li><span>Jan Schröder</span></li><li><span>Stephen J. Turner</span></li><li><span>Phillip K. Darcy</span></li><li><span>Marc D. Beyer</span></li><li><span>Zeinab Abdullah</span></li><li><span>Axel Kallies</span></li></ol></div><h3 id=\"contributions\">Contributions</h3><p>L.H. and A.K. conceived the study, designed the experiments, interpreted the results and wrote the paper. L.H. performed the majority of the experiments with help from M.H.S., S.K.M.W., S.L., N.T.H.-A., C.G.G. and H.H. L.R. performed and analyzed the tumor experiments. Z.A., S.J.T., M.D.B. and D.T.U. contributed to conceptualization and supervision of the study. L.D., A.F., J.S. and M.D.B. performed bioinformatic analyses. M.L.M. and L.H. performed the bulk RNA-seq and ATAC-seq experiments. C.T. performed the scRNA-seq experiment. M.D.B., M.K., D.S. and F.T.W. created the <i>Satb1</i> transgenic and flexed mouse models. C.M.S., M.J.E., J.T., O.H. and P.K.D. performed the CAR T cell experiments. S.L.P., B.v.S. and L.K.M. created the B16-GP33 tumor cell line. S.J.T. provided key reagents.</p><h3 id=\"corresponding-author\">Corresponding author</h3><p>Correspondence to\n                <a target=\"_blank\" href=\"mailto:axel.kallies@unimelb.edu.au\">Axel Kallies</a>.</p></div></div><div><h2 id=\"ethics\">Ethics declarations</h2><div>\n              <h3 id=\"FPar4\">Competing interests</h3>\n              <p>A.K. receives research support from Pfizer. The other authors declare no competing interests.</p>\n          </div></div><div><h2 id=\"peer-review\">Peer review</h2><div>\n              <h3 id=\"FPar3\">Peer review information</h3>\n              <p><i>Nature Immunology</i> thanks Hazem Ghoneim, Charalampos Spilianakis and Tuoqi Wu for their contribution to the peer review of this work. <a target=\"_blank\" href=\"https://www.nature.com/articles/s41590-025-02316-2#MOESM3\">Peer reviewer reports</a> are available. Primary Handling Editor: Laurie A. Dempsey, in collaboration with the <i>Nature Immunology</i> team.</p>\n          </div></div><div><h2 id=\"additional-information\">Additional information</h2><p><b>Publisher’s note</b> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div><div><h2 id=\"Sec37\">Extended data</h2><div><div><h3><a target=\"_blank\" href=\"https://www.nature.com/articles/s41590-025-02316-2/figures/9\">Extended Data Fig. 1 SATB1 limits T<sub>EX</sub> cell differentiation.</a></h3><p><b>(a)</b> Histogram and quantification showing the expression of SATB1 in polyclonal PD-1<sup>+</sup> T<sub>PEX</sub> and T<sub>EX</sub> cells compared to naïve CD8 T cells and B cells (n = 10). <b>(b-e)</b> Naïve SATB1-deficient mice (<i>Satb1</i><sup>flex/flex</sup>/<i>Cd8</i><sup>Cre</sup>, SATB1-KO) or control mice (<i>Satb1</i><sup>flex/flex</sup>) were analyzed using flow cytometry. (b) Flow cytometry plots displaying GFP expression upon Cre-mediated <i>Satb1</i> gene flip in CD8<sup>+</sup> T cells of KO mice compared to control mice (n = 5). <b>(c)</b> Quantification of SATB1 expression in CD4<sup>+</sup> and CD8<sup>+</sup> T cells (n = 5). <b>(d)</b> Numbers of splenic CD4<sup>+</sup> and CD8<sup>+</sup> T cells in SATB1-KO and control mice (n = 5). <b>(e)</b> Flow cytometry plots and quantification showing CD44 vs CD62L expression in SATB1-KO and control mice and quantification of naïve and memory phenotype CD8<sup>+</sup> T cells (n = 5). <b>(f-i)</b> Naïve CD45.2<sup>+</sup> SATB1-KO P14 cells or control cells P14 cells were adoptively transferred into naïve wildtype CD45.1<sup>+</sup> mice and subsequently infected with LCMV-Docile. On day 12, 21, and 28 p.i. spleens were analyzed using flow cytometry. <b>(f)</b> Flow cytometry plots showing frequencies and numbers of SATB1-KO or control T<sub>PEX</sub> and T<sub>EX</sub> cells. <b>(g)</b> Flow cytometry plots and quantification on days 12 (upper) (n = 8) and 21 (lower) (n = 14) p.i. showing frequencies and numbers of SATB1-KO or control CD62L<sup>+</sup> T<sub>PEX</sub> cells. <b>(h)</b> Flow cytometry plots and quantification on day 28 p.i showing the frequencies and numbers of SATB1-KO or control P14 cells (n = 5). <b>(i)</b> Flow cytometry plots and quantification on day 28 p.i showing the numbers of SATB1-KO and control T<sub>PEX</sub>, total T<sub>EX</sub>, CX3CR1<sup>+</sup> T<sub>EX</sub> and CD101<sup>+</sup> T<sub>EX</sub> cells (n = 5). Flow cytometry plots are representative. Dots in graphs represent individual mice; horizontal lines and error bars of bar graphs indicate means ± SEM, respectively. Data are pooled <b>(a,f,g)</b> or representative <b>(b-e, h,i)</b> from two (day 12, day 28 p.i.) or three (day 21 p.i.) independent experiments. <i>P</i> values are from two-tailed unpaired student’s t test.</p></div><div><h3><a target=\"_blank\" href=\"https://www.nature.com/articles/s41590-025-02316-2/figures/10\">Extended Data Fig. 2 SATB1 promotes functionality of exhausted T cells.</a></h3><p><b>(a-h)</b> Naïve CD45.2<sup>+</sup> SATB1-deficient P14 cells (<i>Satb1</i><sup>flex/flex</sup>/<i>Cd8</i><sup>Cre</sup>, SATB1-KO) or control cells (<i>Satb1</i><sup>flex/flex</sup>) P14 cells were adoptively transferred into naïve wildtype CD45.1<sup>+</sup> mice and subsequently infected with LCMV-Docile. On days 12 and 21 p.i. spleens were analyzed using flow cytometry. <b>(a)</b> Flow cytometry plots and quantification of SATB1-KO or control P14 cells producing IFN-γ and TNF and quantification of IFN-γ and TNF expression after incubation with Gp33 peptide <i>ex vivo</i> on day 12 p.i. (n = 5). <b>(b,c)</b> Flow cytometry plots and quantification of SATB1-KO or control T<sub>PEX</sub> cells <b>(b)</b> and T<sub>EX</sub> cells. <b>(c)</b> producing IFN-γ or co-producing IFN-γ and TNF after incubation with Gp33 peptide <i>ex vivo</i> on days 12 (n = 5) and 21 (n = 4) p.i. <b>(d,e)</b> Histogram and quantification showing expression of GzmB <b>(d)</b> and PD-1 <b>(e)</b> in SATB1-KO or control T<sub>EX</sub> cells on day 12 p.i (n = 8). <b>(f)</b> Expression of PD-1 on SATB1-KO and control P14 cells after 66 h of in vitro stimulation (n = 10). <b>(g)</b> Expression of TOX in SATB1-KO or control P14 cells from day 12 of LCMV-Docile infection (n = 8). <b>(h)</b> Viral load in the lungs and kidneys of SATB1-KO or control mice infected with LCMV-Docile on day 31 p.i. (n = 3). Flow cytometry plots are representative. Dots in graphs represent biological replicates; horizontal lines and error bars of bar graphs indicate means ± SEM (a-g) or SD <b>(h)</b>, respectively. Data are representative <b>(a-c, h)</b> or pooled from two <b>(d-g)</b> independent experiments. <i>P</i> values are from two-tailed unpaired student’s t test. PFU, Plaque forming units.</p></div><div><h3><a target=\"_blank\" href=\"https://www.nature.com/articles/s41590-025-02316-2/figures/11\">Extended Data Fig. 3 SATB1 downregulation is required for T<sub>EX</sub> cell differentiation.</a></h3><p><b>(a)</b> Schematic illustrating the generation of <i>Rosa26</i><sup><i>Satb1</i></sup> locus allele. A lox-STOP-lox cassette followed by an <i>Satb1</i>-IRES-GFP sequence was inserted downstream of the CAG promoter region on the <i>Rosa26</i> gene locus. Cre-mediates deletion of the STOP-codon leads to continuously expression of <i>Satb1</i>-GFP. <b>(b-g)</b> Mixed bone marrow chimeric mice containing <i>Satb1</i><sup>Tg</sup> (CD45.2<sup>+</sup>) and control T cells (CD45.1/2<sup>+</sup>) were infected with LCMV-Docile. Spleens were harvested on day 12 and 21 p.i. and analyzed using flow cytometry. (<b>b</b>) Flow cytometry plots and quantification on day 12 p.i. showing frequencies of activated CD44<sup>+</sup> and exhausted PD-1<sup>+</sup> <i>Satb1</i><sup>Tg</sup> or control cells (n = 14). <b>(c)</b> Quantification on day 12 p.i. of CD44 (n = 9) and PD-1 (n = 14) expression among PD-1<sup>+</sup> <i>Satb1</i><sup>Tg</sup> or control cells. <b>(d)</b> Normalized numbers of <i>Satb1</i><sup>Tg</sup> or control T<sub>PEX</sub> and T<sub>EX</sub> cells on day 21 p.i (n = 9). <b>(e)</b> Flow cytometry plots and quantification of <i>Satb1</i><sup><i>Tg</i></sup> or control T<sub>PEX</sub> and T<sub>EX</sub> cells from Day 12 p.i (n = 14). <b>(f,g)</b> Expression of TCF1 (n = 10) and Ly108 (n = 15) (f) and PD-1 (n = 14), TOX (n = 9), and CD44 (n = 13) <b>(g)</b> in <i>Satb1</i><sup><i>Tg</i></sup> or control T<sub>PEX</sub> cells from day 21 p.i. <b>(h)</b> Flow cytometry plots and quantification on days 12 (n = 9) and 21 (n = 14) p.i. showing frequencies of <i>Satb1</i><sup><i>Tg</i></sup> and control CD62L<sup>+</sup> T<sub>PEX</sub> cells. Flow cytometry plots are representative. Dots in graphs represent individual mice; horizontal lines and error bars of bar graphs indicate means ± SEM, respectively. Data are pooled from two <b>(c)</b> or three <b>(b,d-g)</b> independent experiments. <i>P</i> values are from two-tailed paired student’s t test.</p></div><div><h3><a target=\"_blank\" href=\"https://www.nature.com/articles/s41590-025-02316-2/figures/12\">Extended Data Fig. 4 SATB1 expression is required for efficient cytokine production.</a></h3><p>Mixed bone marrow chimeric mice containing <i>Satb1</i><sup>Tg</sup> (CD45.2<sup>+</sup>) and control T cells (CD45.1/2<sup>+</sup>) were infected with LCMV-Docile. On days 12 and 21 p.i. spleens were analyzed using flow cytometry. <b>(a)</b> Quantification of PD-1 expression on day 12 p.i. (n = 9) and 21 p.i. (n = 8), and of TOX (n = 4) expression on day 21 in Gp33<sup>+</sup> <i>Satb1</i><sup>Tg</sup> or control cells. <b>(b)</b> Flow cytometry plots and quantification on day 21 p.i. showing frequencies of <i>Satb1</i><sup>Tg</sup> or control T<sub>PEX</sub> and T<sub>EX</sub> cells among Gp33<sup>+</sup> cells (n = 9). <b>(c-e)</b> Flow cytometry plots and quantification of IFN-γ (n = 13) and TNF (n = 11) production from T<sub>PEX</sub> <b>(c)</b> and T<sub>EX</sub> (n = 13) <b>(d,e)</b> cells after incubation of <i>Satb1</i><sup>Tg</sup> or control CD8 T cells with Gp33 peptide on day 21 p.i. <b>(f)</b> Flow cytometry plots and quantification of IFN-γ and TNF production from <i>Satb1</i><sup>Tg</sup> or control PD-1<sup>+</sup> CD8 T cells after incubation with PMA/Ionomycin (n = 8). <b>(g-l)</b> CTV-labelled SATB1-KO and control P14 cells were adoptively transferred to recipient mice prior to infection with chronic LCMV-Clone13 before analysis on day 3 p.i. <b>(g)</b> Outline of experimental scheme. <b>(h)</b> Flow cytometry plot of control cells and quantification of SATB1 expression per cell division (n = 5). <b>(i)</b> Histogram and quantification of frequencies of TCF1<sup>+</sup> SATB1-KO and control P14 cells per cell division (n = 5). <b>(j)</b> Histogram and quantification of frequencies of CD62L<sup>+</sup> SATB1-KO and control P14 cells per cell division (n = 5). <b>(k)</b> Quantification of PD-1 expression on SATB1-KO and control P14 cells per cell division (n = 5). <b>(l)</b> Flow cytometry plots and quantification of KLRG1 expression on SATB1-KO and control P14 cells in divisions 6 and &gt;7 (n = 5). Flow cytometry plots are representative. Data are representative <b>(h-l)</b> or pooled <b>(a-c)</b> from two or three <b>(d-f)</b> independent experiments. Dots in graphs represent individual mice; horizontal lines and error bars represent indicate means ± SEM, respectively. <i>P</i> values in <b>(a-f)</b> are from two-tailed paired student’s t test.</p></div><div><h3><a target=\"_blank\" href=\"https://www.nature.com/articles/s41590-025-02316-2/figures/13\">Extended Data Fig. 5 SATB1 expression is repressed by TGF-β and limits differentiation of short-lived effect CD8<sup>+</sup> T cells.</a></h3><p><b>(a)</b> Histogram and quantification of SATB1 expression in wild-type CD8<sup>+</sup> T cells that were stimulated <i>in vitro</i> in the presence or absence of titrated doses of TGF-β (n = 8). <b>(b-d)</b> Mixed bone marrow chimeric mice containing TGF-βR2 deficient and control CD8<sup>+</sup> T cells were infected with LCMV-Docile. Spleens were analyzed on day 21 p.i. by flow cytometry. <b>(b)</b> Schematic of experimental set up. <b>(c)</b> SATB1 expression in TGF-βR2 deficient and control Gp33-specific CD8<sup>+</sup> T cells (n = 10). (d) SATB1 expression in TGF-βR2 deficient and control Gp33-specific CD8<sup>+</sup> T cell subsets (n = 10). <b>(e,f)</b> Naïve CD45.1<sup>+</sup> P14 cells were adoptively transferred into naïve wildtype CD45.2<sup>+</sup> mice and infected with LCMV-Armstrong. Spleens were harvested on days 7 or 28 p.i. and analyzed using flow cytometry. <b>(e)</b> Quantification showing the expression of SATB1 in MPC and SLEC cells compared to naïve CD8<sup>+</sup> T cells and B cells (n = 10). <b>(f)</b> Histograms and quantification showing the expression of SATB1 in TCM and TEM cells compared to naïve CD8<sup>+</sup> T cells and B cells (n = 9). <b>(g-n)</b> Naïve CD45.2<sup>+</sup> SATB1-deficient P14 cells (<i>Satb1</i><sup>flex/flex</sup>/<i>Cd8</i><sup>Cre</sup>, SATB1-KO) or control cells (<i>Satb1</i><sup>flex/flex</sup>) P14 cells were adoptively transferred into naïve wildtype CD45.1<sup>+</sup> mice and subsequently infected with LCMV-Armstrong. Mice were analyzed on day 7 p.i. <b>(g)</b> Schematic of experimental set up. <b>(h,i)</b> Flow cytometry plots <b>(h)</b> and quantification <b>(i)</b> of SATB1-KO and control P14 frequencies and numbers per spleen (n = 10). <b>(j)</b> Flow cytometry plots and quantification showing TIM-3 and PD-1 expression in SATB1-KO and control splenic P14 cells (n = 10). (k) Quantification of SATB1-KO and control SLEC and MPC numbers per spleen (n = 10). (l) Flow cytometry plots of IFN-γ and TNF production from SATB1-KO or control SLEC and MPC cells after incubation with Gp33 peptide (n = 10). <b>(m)</b> Quantification of frequencies of IFN-γ and TNF producing SATB1-KO and control SLEC and MPC (n = 10). <b>(n)</b> Quantification of IFN-γ and TNF expression in SATB1-KO and control SLEC and MPC (n = 10). Flow cytometry plots are representative. Dots in graphs represent biological replicates; horizontal lines and error bars of graphs indicate means and SD respectively <b>(a)</b>. Data are pooled from at least two experiments. Dots in graphs represent individual mice <b>(c-n)</b>; horizontal lines and error bars of bar graphs indicate means ± SEM, respectively. <i>P</i> values are from unpaired, two-way ANOVA <b>(e,f)</b>, or two-tailed paired student’s t-tests <b>(c,d)</b>. <i>P</i> values are from unpaired student’s t test <b>(a,i-n)</b>.</p></div><div><h3><a target=\"_blank\" href=\"https://www.nature.com/articles/s41590-025-02316-2/figures/14\">Extended Data Fig. 6 SATB1 downregulation is required for proper effector differentiation in acute viral infection.</a></h3><p><b>(a-c)</b> Naïve CD45.1<sup>+</sup> P14 cells were adoptively transferred into naïve wildtype CD45.2<sup>+</sup> mice and infected with LCMV-Armstrong. Spleens were harvested on days 7 or 28 p.i. and analyzed using flow cytometry. <b>(a)</b> Flow cytometry plots and quantification of SATB1-KO and control CX3CR1 and KLRG1 SLEC populations on day 7 p.i. (n = 10). <b>(b)</b> Histogram and quantification of GzmB producing SATB1-KO or control SLEC on day 7 p.i. (n = 10). <b>(c)</b> Quantification of SATB1-KO (n = 9) and control (n = 10) T<sub>CM</sub> and T<sub>EM</sub> cell numbers per spleen on day 28 p.i. <b>(d-g)</b> Mixed bone marrow chimeric mice containing <i>Satb1</i><sup>Tg</sup> (CD45.2<sup>+</sup>) and control T cells (CD45.1/2<sup>+</sup>) were infected with LCMV-Armstrong. On day 7 p.i. spleens were analyzed using flow cytometry. <b>(d)</b> Flow cytometry plots and quantification of activated CD44<sup>+</sup> <i>Satb1</i><sup>Tg</sup> and control cells (n = 10). <b>(e)</b> Quantification of PD-1 expression in PD-1<sup>+</sup> and Gp33<sup>+</sup> <i>Satb1</i><sup>Tg</sup> and control cells (n = 10). <b>(f)</b> Flow cytometry plots and quantification of CX3CR1 and KLRG1 Gp33<sup>+</sup> <i>Satb1</i><sup>Tg</sup> and control populations (n = 10). <b>(g)</b> Quantification of cytokine expression <i>Satb1</i><sup>Tg</sup> and control cells after Gp33 peptide restimulation (n = 10). Flow cytometry plots are representative. Dots in graphs represent individual mice; horizontal lines and error bars of bar graphs indicate means ± SEM, respectively. Data are pooled from two independent experiments. <i>P</i> values are from two-tailed paired student’s t test.</p></div><div><h3><a target=\"_blank\" href=\"https://www.nature.com/articles/s41590-025-02316-2/figures/15\">Extended Data Fig. 7 Loss of SATB1 does not impact exhausted T cell subset specific chromatin accessibility.</a></h3><p>Naïve CD45.2<sup>+</sup> SATB1-deficient P14 cells (<i>Satb1</i><sup>flex/flex</sup>/<i>Cd8</i><sup>Cre</sup>, SATB1-KO) or control cells (<i>Satb1</i><sup>flex/flex</sup>) P14 cells were adoptively transferred into naïve wildtype CD45.1<sup>+</sup> mice which were subsequently infected with LCMV-Docile. On 21 p.i., CD62L<sup>+</sup> and CD62L<sup>−</sup> T<sub>PEX</sub> and CX3CR1<sup>+</sup> and CD101<sup>+</sup> T<sub>EX</sub> cells were sorted from either SATB1-KO or control spleens and used for RNA and ATAC-sequencing. <b>(a)</b> Comparison of gene accessibility in control CD62L<sup>+</sup> T<sub>PEX</sub>, CD62L<sup>−</sup> T<sub>PEX</sub>, CX3CR1<sup>+</sup> T<sub>EX</sub> and CD101<sup>+</sup> T<sub>EX</sub> cells. <i>TCF7</i>, <i>Irf4</i>, <i>Slamf1</i> and <i>Tgfbr2</i> are shown as examples. <b>(b)</b> Representation of the first two components of a PCA dimensionality reduction based on rlog-transformed counts for all accessible peaks. First component explains 56% and second component explains 19% of total variability. Cell type and genotypes are color coded. <b>(c)</b> K-means clustered heatmap showing normalized counts of all peaks identified using the nextflow pipeline nf-core/atacseq v1.2.1. T<sub>PEX</sub> and T<sub>EX</sub> cell subsets, genotype and replicates are color coded and shown as bars at the top of the heatmap. <b>(d)</b> Proportion of open chromatin peaks identified by ATAC-seq that overlap with SATB1 binding sites as identified by ChIP-seq. <b>(e)</b> Volcano plots showing genes associated with differentially accessible regions (DARs). DARs were identified using the nextflow pipeline nf-core/atacseq v1.2.1, which passed the False Discover Rate (FDR) &lt; 0.05. Genes closest to the respective DAR were identified using Homer v4.11. Each volcano plot shows a SATB1-KO vs Ctrl comparison for each T<sub>PEX</sub> and T<sub>EX</sub> cell subset. Dashed lines: reciprocal adjusted p-value &lt; 0.01 (p<sub>adj</sub><sup>−1</sup> vertical) and log<sub>2</sub> fold change (log2FC) &gt; 1.5 (horizontal). Statistical significance is color coded by passing log2FC and p<sub>adj</sub><sup>−1</sup> cut-offs (red), passing only log2FC- (green) or p<sub>adj</sub><sup>−1</sup> cut-off (blue). Top genes were labelled with the gene name. <b>(f)</b> Volcano plot showing accessible regions in the <i>Ifng</i>, <i>Tnf</i> and <i>Gzmb</i> gene loci. The <i>Gzmb</i> transcriptional start site is highlighted in red. <b>(g)</b> GOEA analysis of genes associated with differentially accessible regions. DARs were used for Gene Ontology Enrichment Analysis (GOEA) using the Hallmark gene sets from the GSEA-MSigDB database as reference. Ontology terms were filtered for an adjusted p-value &lt; 0.05. Each Hallmark term is indicated as the main bubble surrounded by genes belonging to the term. Number of genes belonging to a term is indicated by bubble size. Comparison to identify DARs is indicated by color. Shared terms between comparisons are colored by multiple colors.</p></div><div><h3><a target=\"_blank\" href=\"https://www.nature.com/articles/s41590-025-02316-2/figures/16\">Extended Data Fig. 8 SATB1 binds to genomic regions that show differential accessibility during exhausted T cell differentiation.</a></h3><p><b>(a-c)</b> Naïve CD45.2<sup>+</sup> SATB1-deficient P14 cells (<i>Satb1</i><sup>flex/flex</sup>/<i>Cd8</i><sup>Cre</sup>, SATB1-KO) or control cells (<i>Satb1</i><sup>flex/flex</sup>) P14 cells were adoptively transferred into naïve wildtype CD45.1<sup>+</sup> mice which were subsequently infected with LCMV-Docile. On 21 p.i., CD62L<sup>+</sup> and CD62L<sup>−</sup> T<sub>PEX</sub> and CX3CR1<sup>+</sup> and CD101<sup>+</sup> T<sub>EX</sub> cells were sorted from either SATB1-KO or control spleens and used for RNA and ATAC-sequencing. Shown are SATB1 ChIP binding and gene accessibility in indicated cell types. <b>(a)</b> <i>Ifng</i>, <b>(b)</b> <i>Slamf1</i>, <i>Slamf6</i>, and <b>(c)</b> <i>Arid5a</i>, <i>Ccr5</i> and <i>Prdm1</i>. <b>(d-i)</b> Mixed bone marrow chimeric mice containing SATB1-DNA-binding mutant (<i>Satb1</i><sup>m1Anu/m1Anu</sup>) (CD45.2<sup>+</sup>) and control T cells (CD45.1/2<sup>+</sup>) were infected with LCMV-Docile. On day 21 p.i. spleens were analyzed using flow cytometry. <b>(d)</b> Flow cytometry plots and quantification showing frequencies of activated Gp33<sup>+</sup> <i>Satb1</i><sup>m1Anu/m1Anu</sup> or control cells. <b>(e)</b> Flow cytometry plots and quantification showing frequencies of <i>Satb1</i><sup>m1Anu/m1Anu</sup> or control T<sub>PEX</sub> and T<sub>EX</sub> cells. <b>(f)</b> Expression of TCF1 and Ly108 in Gp33<sup>+</sup> <i>Satb1</i><sup>m1Anu/m1Anu</sup> or control T<sub>PEX</sub> cells. <b>(g)</b> Flow cytometry plots and quantification showing frequencies of <i>Satb1</i><sup>m1Anu/m1Anu</sup> or control CD62L<sup>+</sup> T<sub>PEX</sub> cells. <b>(h)</b> Flow cytometry plots and quantification showing frequencies of <i>Satb1</i><sup>m1Anu/m1Anu</sup> or control CX3CR1<sup>+</sup> and CD101<sup>+</sup> T<sub>EX</sub> cells. <b>(i)</b> Flow cytometry plots and quantification showing frequencies of IFN-γ and TNF producing <i>Satb1</i><sup>m1Anu/m1Anu</sup> or control cells after stimulation with Gp33 peptide <i>ex vivo</i>. Flow cytometry plots are representative. Dots in graphs represent individual mice; horizontal lines and error bars of bar graphs indicate means ± SEM, respectively. Data are pooled from two independent experiments. <i>P</i> values are from two-tailed unpaired student’s t test.</p></div><div><h3><a target=\"_blank\" href=\"https://www.nature.com/articles/s41590-025-02316-2/figures/17\">Extended Data Fig. 9 SATB1 limits tumor control and response to checkpoint inhibition.</a></h3><p>Naïve CD45.2<sup>+</sup> SATB1-deficient P14 cells (<i>Satb1</i><sup>flex/flex</sup>/<i>Cd8</i><sup>Cre</sup>, SATB1-KO) or control cells (<i>Satb1</i><sup>flex/flex</sup>) P14 cells were adoptively transferred into naïve wildtype CD45.1<sup>+</sup> mice 3 days after inoculation with B16/Gp33<sup>+</sup> Tumor cells. Mice were treated with immune checkpoint blockade (ICB, anti-PDL-1 + anti-CTLA4) or PBS. <b>(a,b)</b> Tumor growth <b>(a)</b> and survival <b>(b)</b> of mice transferred with either SATB1-KO or control P14 cells treated with or without ICB (n = 8). Data are pooled from two independent experiments. <b>(c,d)</b> Representative flow cytometry plots and quantification showing the frequencies of IFN-γ and TNF producing SATB1-KO and Control P14 cells in the tumor <b>(c)</b> and tdLNs <b>(d)</b> treated with or without ICB after <i>ex vivo</i> restimulation with Gp33 peptide (untreated n = 8, treated KO n = 5, treated WT n = 7). Dots in graphs represent individual mice; horizontal lines and error bars of bar graphs indicate means ± SEM, respectively. Data are pooled from two independent experiments. <i>P</i> values are from two-way ANOVA <b>(b)</b> or unpaired student’s t test <b>(c,d)</b>.</p></div><div><h3><a target=\"_blank\" href=\"https://www.nature.com/articles/s41590-025-02316-2/figures/18\">Extended Data Fig. 10 SATB1 limits effector differentiation of CD8<sup>+</sup> T cells in tumor draining lymph nodes.</a></h3><p>Naïve CD45.2<sup>+</sup> SATB1-deficient P14 cells (<i>Satb1</i><sup>flex/flex</sup>/<i>Cd8</i><sup>Cre</sup>, SATB1-KO) or control cells (<i>Satb1</i><sup>flex/flex</sup>) P14 cells were adoptively transferred into naïve wildtype CD45.1<sup>+</sup> mice 3 days after inoculation with B16/Gp33 tumor cells. Mice were treated with immune checkpoint blockade (ICB, anti-PDL-1 + anti-CTLA4) or PBS on indicated days. Tumor draining LN (tdLNs) were harvested on day 16 after inoculation and analyzed using flow cytometry. <b>(a)</b> Representative flow cytometry plots and quantification showing frequencies and numbers of SATB1-KO or control P14 cells (untreated n = 8, treated KO n = 6, treated WT n = 7). <b>(b)</b> Representative flow cytometry plots and quantification showing frequencies and numbers SATB1-KO or control CX3CR1<sup>+</sup> T<sub>EX</sub> cells (untreated n = 8, treated KO n = 6, treated WT n = 7). <b>(c)</b> Representative flow cytometry plots and quantification showing frequencies and numbers of GzmB producing SATB1-KO or control P14 cells (untreated n = 8, treated KO n = 6, treated WT n = 7). Dots in graphs represent individual mice; horizontal lines and error bars of bar graphs indicate means ± SEM, respectively. Data are representative of two independent experiments. <i>P</i> values are from unpaired student’s t test.</p></div></div></div><div><h2 id=\"Sec38\">Supplementary information</h2></div><div><h2 id=\"rightslink\">Rights and permissions</h2><div><p>Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</p><p><a target=\"_blank\" href=\"https://s100.copyright.com/AppDispatchServlet?title=Transcriptional%20regulator%20SATB1%20limits%20CD8%2B%20T%20cell%20population%20expansion%20and%20effector%20differentiation%20in%20chronic%20infection%20and%20cancer&amp;author=Leonie%20Heyden%20et%20al&amp;contentID=10.1038%2Fs41590-025-02316-2&amp;copyright=The%20Author%28s%29%2C%20under%20exclusive%20licence%20to%20Springer%20Nature%20America%2C%20Inc.&amp;publication=1529-2908&amp;publicationDate=2025-10-27&amp;publisherName=SpringerNature&amp;orderBeanReset=true\">Reprints and permissions</a></p></div></div><div><h2 id=\"article-info\">About this article</h2><div><h3 id=\"citeas\">Cite this article</h3><p>Heyden, L., Rausch, L., Shannon, M.H. <i>et al.</i> Transcriptional regulator SATB1 limits CD8<sup>+</sup> T cell population expansion and effector differentiation in chronic infection and cancer.\n                    <i>Nat Immunol</i>  (2025). https://doi.org/10.1038/s41590-025-02316-2</p><p><a target=\"_blank\" href=\"https://citation-needed.springer.com/v2/references/10.1038/s41590-025-02316-2?format=refman&amp;flavour=citation\">Download citation</a></p><ul><li><p>Received<span>: </span><span>28 October 2024</span></p></li><li><p>Accepted<span>: </span><span>22 September 2025</span></p></li><li><p>Published<span>: </span><span>27 October 2025</span></p></li><li><p><abbr title=\"Digital Object Identifier\">DOI</abbr><span>: </span><span>https://doi.org/10.1038/s41590-025-02316-2</span></p></li></ul></div></div>\n            </div>",
  "author": "Kallies, Axel",
  "favicon": "https://www.nature.com/static/images/favicons/nature/favicon.ico",
  "source": "nature.com",
  "published": "2025-10-27",
  "ttr": 1170,
  "type": "article"
}